Specific price of pomalidomide capsules

Pomalidomide(Pomalidomide) is one of the important drugs in the global multiple myeloma (MM) treatment field. It is mostly used for patients who still have disease progression after previous treatments. Its main effects come from mechanisms such as immune regulation, inhibition of tumor microenvironment response, and anti-angiogenesis. Therefore, it is often used in combination with dexamethasone or other drugs to enhance the overall therapeutic response. In recent years, pomalidomide has been officially launched in China and has been included in the medical insurance directory, allowing many patients to receive long-term treatment in a more affordable way. Since pomalidomide is a long-term management drug, the original research price is higher, and most patients bear greater pressure before medical insurance reimbursement.

The domestic market is dominated by original research versions, and prices are affected by multiple factors such as medical insurance policies, hospital bargaining mechanisms, and regional pharmaceutical supply systems. Therefore, the actual post-reimbursement prices may differ in different provinces and cities. Under normal circumstances, patients can consult the hospital pharmacy for specific costs, or they can choose to obtain drugs periodically based on the drug supply method. In order to provide more patients with access to treatment, there is also a relatively cheaper Laotian generic version abroad. Its ingredients are consistent with the original research, but the price is only about RMB 300 (the actual amount will fluctuate with exchange rate changes). Since generic drugs need to be purchased through formal channels to ensure quality, when choosing non-original versions, attention must be paid to the reliability of the drug source, safety certification, and storage conditions to avoid unstable drug effects or increased risks due to unknown channels.

From the perspective of practical application, the dosage of pomalidomide is usually adjusted according to the treatment cycle, and patients need to assess their blood count, renal function, and infection risk before taking the drug. This is why its price is closely related to the consumption of medical resources. Patients also need to regularly review their indicators during long-term medication, so the overall treatment cost includes not only the drug price, but also monitoring costs and incidental support treatment expenses.

Reference materials:https://en.wikipedia.org/wiki/Pomalidomide